Xylem opens new distribution and customer service base in Moscow
March 22, 2012
MOSCOW, RUSSIA — Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, today announced that it has opened a new distribution and customer service base in Moscow, Russia. Part of a long-term growth strategy, Xylem’s expanded presence in Russia will focus on boosting sales and [...]
Corning Names Dr. David L. Morse Chief Technology Officer
March 22, 2012
CORNING, N.Y., – Corning Incorporated (NYSE: GLW) today announced that the company’s board of directors is expected to elect David L. Morse, Ph.D., as executive vice president and chief technology officer at its meeting on April 26, 2012. His appointment will be effective May 1, at which time he will also become a member of [...]
PREMIER Biosoft Releases Beacon Designer™ 8.0 with Support for Exon Junction Primer Design
March 22, 2012
PREMIER Biosoft International, Palo Alto, California – PREMIER Biosoft today announced the release of the latest version of its comprehensive real time oligo design tool, Beacon Designer™ 8.0 with the ability to design primers across exon-exon and exon-intron junctions for selectively amplifying cDNA from a mixture of genomic DNA. The exons and introns are identified [...]
Hanna Instruments, Inc. Adds Tectron as Exclusive Kuwait Distribution Partner
March 22, 2012
WOONSOCKET, R.I --Hanna Instruments is pleased to announce it has partnered with Tectron as its exclusive distributor in Kuwait for scientific analytical instrumentation. Hanna Instruments, Inc., manufacturer of electro analytical instrumentation, and Tectron, a Kuwait based distributor and professional service contractor of scientific equipment, have teamed up to provide users of analytical devices with an [...]
Macrogen, Inc. Increases Investment in Illumina’s Next-Generation Sequencing Technology
March 22, 2012
SAN DIEGO -- Illumina today announced that Macrogen, Inc., a global sequencing services company based in Korea, purchased an additional ten Illumina HiSeq 2000 systems and two MiSeq systems, as well as HiSeq 2500 upgrades. This strategic scale-up expands Macrogen’s capacity with Illumina’s sequencing systems and will be completed by the end of 2012. “Macrogen’s [...]
Thermo Fisher Scientific Announces 510(k) Clearance of ImmunoCAP Tryptase Assay
March 22, 2012
PORTAGE, Mich -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its immunodiagnostics business has received 510(k) clearance of the Thermo Scientific ImmunoCAP Tryptase Assay for use on its Thermo Scientific Phadia Laboratory Systems line of automated laboratory instruments. ImmunoCAP Tryptase is the first commercially available assay in the U.S. [...]
FDA clears Asuragen’s RNARetain® Pre-analytical RNA Stabilization Device
March 22, 2012
Austin, Texas – Asuragen, Inc. announced today the FDA clearance of RNARetain®, the Company’s clinically validated and cGMP manufactured sample collection and cellular RNA preservation device. Based upon patented technology, RNARetain is labeled for the collection, storage, and transportation of fresh breast tissue specimens for subsequent RNA isolation and further molecular diagnostic testing. The cGMP [...]
March 22, 2012
SANTA CLARA, Calif.,– LumaSense Technologies, Inc. today introduced a new category of dissolved-gas analysis (DGA) monitors that allow electric utilities to more effectively reduce outages caused by faulty load tap changers (LTC’s) and transformers. At a cost significantly less expensive than comparable DGA monitors and a unique hardware design that drastically cuts down installation time, [...]
Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
March 22, 2012
The new Dynaflow Resolve System was developed in close collaboration with leading ion-channel research groups to meet the demand for a simpler technology capable of complex perfusion protocols. The Dynaflow Resolve System is an advanced automated perfusion system that enables novel experimental protocols by allowing recording of any ion channel current, using any cell type, [...]
High Sensitivity Troponin-I Assay Could Identify Future Risk for Dying from Cardiovascular Disease
March 22, 2012
A study to be published in the journal Clinical Chemistry has shown that a high sensitivity cardiac troponin-I (cTnI) assay from Singulex, Inc. could be used to identify, in healthy asymptomatic people, an increased risk of dying from cardiovascular disease (CVD) eight to 15 years in the future. This proprietary assay (Erenna® cTnl Immunoassay) is [...]
